We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VCKA market cap is 1.41B. The company's latest EPS is USD -0.7332 and P/E is -0.70.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 12.58M | 10.12M | 13.46M | 17.78M | 16.37M |
| Operating Income | -22.81M | -38.81M | -18.34M | -19.48M | -15.62M |
| Net Income | -26.65M | -35.53M | -21.4M | -24.38M | -37.58M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 38.03M | 46.74M |
| Operating Income | -6k | -1.01M | -50.63M | -105.43M |
| Net Income | -6k | 783k | -23.36M | -114.33M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 126.46M | 80.53M | 101.31M | 91.24M | 104.54M |
| Total Liabilities | 116.05M | 243.2M | 274.25M | 281.03M | 319.24M |
| Total Equity | 10.42M | -162.67M | -172.94M | -189.79M | -214.69M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 199k | 139.92M | 86.53M | 101.31M |
| Total Liabilities | 180k | 9.24M | 50.29M | 274.25M |
| Total Equity | 19k | -8.7M | 36.24M | -172.94M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -21.22M | -15.32M | -20.71M | 9.39M | 11.7M |
| Investing | -8k | -163k | -330k | -150k | -300k |
| Financing | 54.17M | 15.28M | 23.58M | -11.2M | -6.47M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1,000 | -802k | -21.26M | -20.71M |
| Investing | N/A | -139.38M | -2.07M | -330k |
| Financing | 32k | 140.66M | 21.17M | 23.58M |
| Market Cap | 1.41B |
| Price to Earnings Ratio | -0.70 |
| Price to Sales Ratio | 1.7 |
| Price to Cash Ratio | 20.32 |
| Price to Book Ratio | -0.46 |
| Dividend Yield | - |
| Shares Outstanding | 155.94M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.18 (1.73%) |
| Company Name | Vickers Vantage Corporation I |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.scilexholding.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
